Showing results (2191-2200 of 2,695) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|March 21, 2002
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequencesDominique Sanglard, Frank C Odds
The Lancet. Infectious Diseases|March 15, 2002
Evidence for infectious agents in cardiovascular disease and atherosclerosisMaija Leinonen, Pekka Saikku
The Lancet. Infectious Diseases|March 15, 2002
Estimates of world-wide distribution of child deaths from acute respiratory infectionsBrian G Williams, Eleanor Gouws, Cynthia Boschi-Pinto, et al.
The Lancet. Infectious Diseases|February 15, 2021
Genomic-informed pathogen surveillance in Africa: opportunities and challengesSeth C Inzaule, Sofonias K Tessema, Yenew Kebede, et al.
The Lancet. Infectious Diseases|February 19, 2021
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for MicrobiologyMartin Hoenigl, Jon Salmanton-García, Thomas J Walsh, et al.
The Lancet. Infectious Diseases|February 26, 2021
Scaling up COVID-19 rapid antigen tests: promises and challengesRosanna W Peeling, Piero L Olliaro, Debrah I Boeras, et al.
The Lancet. Infectious Diseases|July 27, 2019
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic studyRob W van der Pluijm, Mallika Imwong, Nguyen Hoang Chau, et al.
The Lancet. Infectious Diseases|September 1, 2019
Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort studyLuis C Berrocal-Almanza, Ross Harris, Maeve K Lalor, et al.
The Lancet. Infectious Diseases|September 3, 2019
Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trialWilliam O'Riordan, Carrie Cardenas, Elliot Shin, et al.
The Lancet. Infectious Diseases|November 10, 2018
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysisAlessandro Cassini, Liselotte Diaz Högberg, Diamantis Plachouras, et al.
Pageof 270